Literature DB >> 18253719

Chromosomal instability in bladder cancer.

Andrea R Florl1, Wolfgang A Schulz.   

Abstract

Chromosomal instability (CIN) distinguishes invasive urothelial carcinomas from less malignant papillary subtypes. Recent results implicate checkpoint dysfunction as a crucial factor underlying the emergence of aneuploidy in urothelial carcinogenesis. It may moreover contribute to DNA repair defects. Therefore, defects in cell cycle regulation, p53 function, and checkpoint signaling initially caused by carcinogens in the urothelium could ultimately elicit CIN. Among several mechanisms contributing to aneuploidy, breakage-fusion-bridge (BFB) cycles initiated by defective telomeres may be particularly relevant. The mechanism generating large interstitial deletions, prominently at 9p21, appears to be distinct. New experimental approaches are required to address important unresolved questions such as the precise relationship between telomere erosion and telomerase activation, the influence of checkpoint defects on DNA double-strand repair by non-homologous and homomologous recombination repair systems, and the mechanism responsible for megabase-sized interstitial deletions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18253719     DOI: 10.1007/s00204-008-0280-3

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  21 in total

1.  High expression of spindle assembly checkpoint proteins CDC20 and MAD2 is associated with poor prognosis in urothelial bladder cancer.

Authors:  Jung-Woo Choi; Younghye Kim; Ju-Han Lee; Young-Sik Kim
Journal:  Virchows Arch       Date:  2013-08-31       Impact factor: 4.064

2.  Hexavalent chromium induces chromosome instability in human urothelial cells.

Authors:  Sandra S Wise; Amie L Holmes; Louis Liou; Rosalyn M Adam; John Pierce Wise
Journal:  Toxicol Appl Pharmacol       Date:  2016-02-18       Impact factor: 4.219

Review 3.  Chromosomal instability and cancer: a complex relationship with therapeutic potential.

Authors:  Samuel F Bakhoum; Duane A Compton
Journal:  J Clin Invest       Date:  2012-04-02       Impact factor: 14.808

4.  [Signal transduction in urothelial cancer: how exactly do we know the targets for targeted therapy?].

Authors:  G Niegisch; A Koch; J Knievel; W A Schulz; P Albers
Journal:  Urologe A       Date:  2010-11       Impact factor: 0.639

5.  Identification of differently expressed genes in chemical carcinogen-induced rat bladder cancers.

Authors:  Guangfu Chen; Franky L Chan; Xu Zhang; Peter S F Chan
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2009-04-28

6.  Insights into cancer mechanisms from genomic research on urological cancers.

Authors:  Wolfgang A Schulz; Teodora Ribarska
Journal:  Genome Med       Date:  2011-03-31       Impact factor: 11.117

7.  Significant Correlation between Chromosomal Aberration and Nuclear Morphology in Urothelial Carcinoma.

Authors:  Masayo Shuto; Atsushi Seyama; Yoshiya Gotoh; Kouichi Kamada; Masaru Nakamura; Kenji Warigaya; Hiroshi Watanabe; Munehisa Ueno; Michio Shimizu; Toshio Fukuda; Shin-Ichi Murata
Journal:  Acta Histochem Cytochem       Date:  2012-01-24       Impact factor: 1.938

8.  Concomitant downregulation of the imprinted genes DLK1 and MEG3 at 14q32.2 by epigenetic mechanisms in urothelial carcinoma.

Authors:  Annemarie Greife; Judith Knievel; Teodora Ribarska; Günter Niegisch; Wolfgang A Schulz
Journal:  Clin Epigenetics       Date:  2014-11-23       Impact factor: 6.551

9.  Chromosomal instability as a prognostic marker in cervical cancer.

Authors:  Christine How; Jeff Bruce; Jonathan So; Melania Pintilie; Benjamin Haibe-Kains; Angela Hui; Blaise A Clarke; David W Hedley; Richard P Hill; Michael Milosevic; Anthony Fyles; Fei-Fei Liu
Journal:  BMC Cancer       Date:  2015-05-06       Impact factor: 4.430

10.  Copy Number Variations of CEP63, FOSL2 and PAQR6 Serve as Novel Signatures for the Prognosis of Bladder Cancer.

Authors:  Zhao Cai; Huang Chen; Jingqiao Bai; Yang Zheng; Jianhui Ma; Xiongwei Cai; Yu Liu; Kaitai Zhang; Jianzhong Shou; Yanning Gao
Journal:  Front Oncol       Date:  2021-05-10       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.